Skip to Main Content
Contribute Try STAT+ Today
Trending:
Coronavirus
First Opinion
Biotech
Health
Trending
Woodcock
‘There’s no free lunch with drugs’: Janet Woodcock talks…
‘There’s no free lunch with drugs’: Janet Woodcock talks Covid monoclonal antibodies and pediatric vaccines
Knee x-ray
Researching collagen to help his achy knees, a statistician…
Researching collagen to help his achy knees, a statistician explores the painfully weak evidence
Janet Jackson
The science behind Janet Jackson’s pregnancy at 49
The science behind Janet Jackson’s pregnancy at 49
Recommended
Early data indicate vaccines still protect against Omicron’s sister…
Early data indicate vaccines still protect against Omicron’s sister variant, BA.2
In ‘chemo brain,’ researchers see clues to unravel long…
In ‘chemo brain,’ researchers see clues to unravel long Covid’s brain fog
Some Americans are hesitant about Covid vaccines. But they’re…
Some Americans are hesitant about Covid vaccines. But they’re all-in on unproven treatments

Recommended Stories

Covid end of year
Health

10 lessons I’ve learned from the Covid-19 pandemic

By Helen Branswell

Health

Some Americans are hesitant about Covid vaccines. But they’re all-in on unproven treatments

By Lev Facher

Biotech stock crash
Biotech

‘Nowhere to hide’: As biotech stocks plummet, an industry is being reshaped by the fallout

By Adam Feuerstein, Damian Garde and Matthew Herper

Stock exchange
Biotech

Biotech stocks are a dumpster fire. An analyst explains what’s going on

By Adam Feuerstein, Meg Tirrell and Damian Garde

Health Tech

‘We must change’: Health systems invest more aggressively than ever in digital health

By Casey Ross